Delivery Order SPE2DB20D6036-SPE2DB24FC8EQ
Award Date 1/3/24
Potential Completion Date 1/4/24
Potential Value $3.7K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,693.66 firm-fixed-price delivery order is for the supply of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of October 12, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $30,017.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a prescription medication used to prevent nausea and vomiting. The contract has an ultimate completion date of December 8, 2023 and is a Firm Fixed Price Delivery Order. The contract was awarded on December 7, 2022 without any set-aside designation, indicating open...
- This federal contract award, valued at $3,379.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of 4,560,993,787 units of Ondansetron ODT 4 mg Tablet 30s, a pharmaceutical product. The contract has an ultimate completion date of May 22, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
- This federal contract award, valued at $22,448.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ondansetron ODT 4 mg tablets to support military healthcare programs. It is a firm-fixed-price delivery order with an ultimate completion date of April 28, 2023. The contract was awarded through full and open competition, without any set-aside designation. Amerisourcebergen Drug Corp is a major...
- The federal contract award SPE2DX15D3012|SPE2DX24F8DS6 was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $22,875.75, is for the delivery of 4,562,762,161 units of Ondansetron ODT 4 mg tablets. This is a firm fixed-price delivery order contract with a completion date of November 9, 2023. The contract was not designated with a set-aside requirement, indicating open competition....
- This federal contract award, worth $12,645.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a completion date of May 22, 2023 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $1,463.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,490,062 units of Ondansetron ODT 4 MG Tablet 30S, a medication used to treat nausea and vomiting. The award has an ultimate completion date of January 31, 2024 and is a Firm Fixed Price Delivery Order contract. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
- This federal contract award, valued at $7,612.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4563004203 - Ondansetron ODT 4 mg Tablet 30s, a medication used to treat nausea and vomiting. The award is a Firm Fixed Price Delivery Order with a performance period ending on December 6, 2023. The contract was awarded through full and open competition, with no set-aside designation. Amerisourcebergen...
- This federal contract award, valued at $4,726.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of ondansetron odt 4 mg tablets, a medication used to treat nausea and vomiting. The contract is a delivery order with a firm fixed price and has an ultimate completion date of September 8, 2023. There was no set-aside designation for this award. Amerisourcebergen Drug Corp holds a...
- This federal contract award, valued at $12,439.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for 4,562,987,605 units of the medication Ondansetron ODT 4 mg tablet, a generic drug used to treat nausea and vomiting. The contract has an ultimate completion date of December 5, 2023 and a firm fixed price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen Drug...